Top Markets
Coin of the day
Edesa Biotech, Inc. Edesa Biotech, Inc.

Edesa Biotech, Inc.

EDSA
Rangering i aksjer #25795
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering,... Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based in Markham, Canada.
Aksjekurs
$4.80
Markedsverdi
$46.24M
Endring (1 dag)
-16.52%
Endring (1 år)
103.39%
Land
CA
Handel Edesa Biotech, Inc. (EDSA)

Kategori

Aksjeprishistorikk for Edesa Biotech, Inc. (EDSA)
Høyeste sluttskurs: $5.37 den 2026-08-01

Laveste sluttskurs: $602.70 den 2010-06-01
Aksjeprishistorikk for Edesa Biotech, Inc. fra 2010 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 188.73%
2025 -16.90%
2024 -58.03%
2023 -48.53%
2022 -77.76%
2021 16.75%
2020 12.06%
2019 -29.49%
2018 -84.76%
2017 -54.18%
2016 -73.20%
2015 -32.44%
2014 -36.36%
2013 592.43%
2012 -41.11%
2011 -62.20%
2010 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$539.14 36.71%
US
$1.04K 56.86%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$130.43 385.07%
US